Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas

Modern Pathology

Volumn 24, Issue 4, 2011, Pages 533-541

  Tsutsumi, Kosuke ^a   Sato, Norihiro ^a   Cui, Lin ^a   Mizumoto, Kazuhiro ^a   Sadakari, Yoshihiko ^a   Fujita, Hayato ^a   Ohuchida, Kenoki ^a   Ohtsuka, Takao ^a   Takahata, Shunichi ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

claudin 4 (CLDN4); formalin fixed paraffin embedded tissues; high grade intraductal papillary mucinous neoplasms; intestinal type intraductal papillary mucinous neoplasms; intraductal papillary mucinous neoplasms (IPMNs); pancreatic juices

Indexed keywords

CLAUDIN 4; MESSENGER RNA;

ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, MUCINOUS; ADENOMA; CARCINOMA, PANCREATIC DUCTAL; CELL DIFFERENTIATION; CELL LINE, TUMOR; FIXATIVES; FORMALDEHYDE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JAPAN; MEMBRANE PROTEINS; NEOPLASM STAGING; PANCREATIC JUICE; PANCREATIC NEOPLASMS; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 79953295534     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.218     Document Type: Article

References (33)

1. Longnecker DS, Alder G, Hruban RH, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. IARC Press: Lyon, France, 2000, pp 237-240.
2. Tanaka M, Kobayashi K, Mizumoto K, et al. Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol 2005;40:669-675. (Pubitemid 41349077)
3. Sadakari Y, Ohuchida K, Nakata K, et al. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery 2010;147:812-817.
4. Furukawa T, Klöppel G, Volkan Adsay N, et al. Classification of types of intraductal papillarymucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005;447:794-799. (Pubitemid 41728866)
5. Andrejevic-Blant S, Kosmahl M, Sipos B, et al. Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity. Virchows Arch 2007;451:863-869. (Pubitemid 350060751)
6. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
7. Sessa F, Solcia E, Capella C, et al. Intraductal papillarymucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994; 425:357-367.
8. Laghi L, Orbetegli O, Bianchi P, et al. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers. Oncogene 2002;21:4301-4306. (Pubitemid 34753836)
9. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol 2000;157:755-761. (Pubitemid 32109368)
10. Biankin AV, Biankin SA, Kench JG, et al. Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma. Gut 2002;50:861-868. (Pubitemid 34539051)
11. Sahin F, Maitra A, Argani P, et al. Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms. Mod Pathol 2003;16:686-691. (Pubitemid 36871502)
12. Sato N, Ueki T, Fukushima N, et al. Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2002;123:365-372. (Pubitemid 34747556)
13. House MG, Guo M, Iacobuzio-Donahue C, et al. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 2003;24:193-198. (Pubitemid 36267086)
14. Sato N, Fukushima N, Maitra A, et al. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol 2004;164:903-914. (Pubitemid 38235472)
15. Hough CD, Sherman-Baust CA, Pizer ES, et al. Largescale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000;60:6281-6287.
16. Kominsky SL, Vali M, Korz D, et al. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am J Pathol 2004;164:1627-1633. (Pubitemid 38529765)
17. Long H, Crean CD, Lee WH, et al. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 2001;61:7878-7881. (Pubitemid 33049378)
18. Michl P, Buchholz M, Rolke M, et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001;121:678-684. (Pubitemid 32822583)
19. Ryu B, Jones J, Blades NJ, et al. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res 2002;62:819-826. (Pubitemid 34126959)
20. Iacobuzio-Donahue CA, Maitra A, Olsen M, et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003;162:1151-1162. (Pubitemid 36350660)
21. Nichols LS, Ashfaq R, Iacobuzio-Donahue CA. Claudin . 4. protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am J Clin Pathol 2004;121:226-230. (Pubitemid 38140127)
22. Hewitt KJ, Agarwal R, Morin PJ. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006;6:186.
23. Morita K, Furuse M, Fujimoto K, et al. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 1999;96:511-516. (Pubitemid 29061239)
24. Sato N, Mizumoto K, Beppu K, et al. Establishment of a new human pancreatic cancer cell line, NOR-P1, with high angiogenic activity and metastatic potential. Cancer Lett 2000;155:153-161. (Pubitemid 30259129)
25. Ohuchida K, Mizumoto K, Murakami M, et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 2004;64:3215-3222. (Pubitemid 38581425)
26. Sato N, Maitra A, Fukushima N, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003;63:4158-4166. (Pubitemid 36917941)
27. Ryu B, Jones J, Hollingsworth MA, et al. Invasionspecific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 2001;61:1833-1838. (Pubitemid 32691994)
28. Terris B, Blaveri E, Crnogorac-Jurcevic T, et al. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas. Am J Pathol 2002;160:1745-1754. (Pubitemid 34525654)
29. Tsukahara M, Nagai H, Kamiakito T, et al. Distinct expression patterns of claudin-1 and claudin-4 in intraductal papillary-mucinous tumors of the pancreas. Pathol Int 2005;55:63-69. (Pubitemid 40343725)
30. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an 'intestinal' pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848. (Pubitemid 38856838)
31. Nakata K, Nagai E, Ohuchida K, et al. REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms. Mod Pathol 2009;22:460-468.
32. Suzuki M, Kato-Nakano M, Kawamoto S, et al. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 2009;100:1623-1630.
33. Kakutani H, Kondoh M, Saeki R, et al. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin. Eur J Pharm Biopharm 2010;75: 213-217.